Product Information
STEGLUJAN 5-100 MG TABLET is a brand product labeled by Merck Sharp & Dohme LLC, priced at $17.4091 per EA under NDC 00006536703. Its NADAC has been published 261 times since Feb 19, 2020.
FDA first approved this application on Dec 19, 2017.
Strength
5; 100 mg/1; mg/1
Manufacturer
Merck Sharp & Dohme LLCNDC
00006536703
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
6/18/2025
Active Ingredients
ERTUGLIFLOZIN PIDOLATE; SITAGLIPTIN PHOSPHATEApproval Type
New Drug (NDA)
FDA Application
NDA209805FDA Approved
12/19/2017
On Market Since
12/19/2017
Pharmacological Classes
Price Statistics
The NADAC for STEGLUJAN 5-100 MG TABLET has been published 261 times since Feb 19, 2020, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $17.4091 per EA |
|---|---|
| All-time high | $17.7128 (Jan 11, 2023) |
| All-time low | $17.4091 (Jun 18, 2025) |
| 52-week high | $17.4091 |
| 52-week low | $17.4091 |
| Median price | $17.4988 |
| Average price | $17.5461 |
| Largest weekly change | +1.2% (Jan 19, 2022) |
| Weeks tracked | 261 |
| Tracking since | Feb 19, 2020 |
1W
N/A
1M
N/A
3M
0.0%
6M
0.0%
1Y
0.0%
3Y
-1.7%
5Y
-0.5%
All
-1.7%
Last surveyed Jun 10, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of STEGLUJAN 5-100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for STEGLUJAN 5-100 MG TABLET, manufactured by Merck Sharp & Dohme LLC, is $17.4091 per EA (NDC 00006536703), effective Jun 10, 2026.
How has the price of STEGLUJAN 5-100 MG TABLET changed over time?
Over the history we have for it, the NADAC for STEGLUJAN 5-100 MG TABLET has held within roughly two percent of its current level. It has been tracked across 261 weekly CMS publications since Feb 19, 2020.
What are the highest and lowest recorded NADAC prices for STEGLUJAN 5-100 MG TABLET?
Since Feb 19, 2020, the NADAC for STEGLUJAN 5-100 MG TABLET has ranged from a low of $17.4091 (Jun 18, 2025) to a high of $17.7128 (Jan 11, 2023), with a median of $17.4988 per EA.
Are there cheaper alternatives to STEGLUJAN 5-100 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as STEGLUJAN 5-100 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures STEGLUJAN 5-100 MG TABLET?
STEGLUJAN 5-100 MG TABLET (NDC 00006536703) is labeled by Merck Sharp & Dohme LLC, and CMS classifies it as a brand product.